Morales ML, Sendra C, Romero-Gomez M

Language: English
References: 7
Page: 185-187
PDF size: 104.73 Kb.

ABSTRACT

Hepatitis B virus infection seems to protect against steatosis and insulin resistance decreasing NAFLD. Metabolic syndrome has been associated with increased risk of disease progression to cirrhosis and liver cancer in hepatitis B. HBsAg seroclearance increased over time and it could be a confounding factor when analysing NAFLD and hepatitis B prevalence.

REFERENCES

1. Cheng HY, Wang HY, Chang WH, Lin SC, Chu CH, Wang TE, Liu CC, et al. Nonalcoholic Fatty Liver Disease: Prevalence, influence on Age and Sex, and relationship with metabolic syndrome and insulin resistance. Int J Gerontol 2013; 7: 194-8.

2. Wong VW, Wong GL, Chu WC, Chim AM, Ong A, Yeung DK, Yiu KK, et al. Hepatitis B virus infection and fatty liver in the general population. J Hepatol 1012; 56: 533-40.

3. Wong GL, Chan HL, Yu Z, Chan AW, Choi PC, Chim AM, Chan HY, et al. Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B: a prospective cohort study with paired transient elastography examinations. Aliment Pharmacol Ther 2014; 39: 883-93.

4. Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology 2007; 45: 1187-92.

5. Machado MV, Oliveira AG, Cortez-Pino H. Hepatic steatosis in hepatitis B virus infected patients: Meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol 2011; 26: 1361-7.

6. Cheng YL, Wang YJ, Kao WY, Chen PH, Huo TI, Huang YH, Lan KH, et al. Inverse association between Hepatitis B virus infection and fatty liver disease : A large-scale study in populations seeking for check-up. Plos One 2013; 8: e72049.

7. Joo EJ, Chang Y, Yeom JS, Ryu S. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study. Hepatology 2017 [In press]. Doi: 10.1002/ hep.28917.